Clinical Evaluation and Biomarker Profiling of Hsp90 InhibitorsAkira Yuno, Jane B. Trepel, Yusuke Tomita et al.|Methods in molecular biology|2017Cited by 122
A novel tumor‐associated antigen, cell division cycle 45‐like can induce cytotoxic T‐lymphocytes reactive to tumor cellsYusuke Tomita, Yasuharu Nishimura, Katsunori Imai et al.|Cancer Science|2011Cited by 46
Identification of SPARC as a candidate target antigen for immunotherapy of various cancersMitsuhiro Inoue, Yasuharu Nishimura, Hideo Baba et al.|International Journal of Cancer|2010Cited by 39
Identification of immunogenic LY6K long peptide encompassing both CD4<sup>+</sup>and CD8<sup>+</sup>T-cell epitopes and eliciting CD4<sup>+</sup>T-cell immunity in patients with malignant diseaseYusuke Tomita, Yasuharu Nishimura, Akira Yuno et al.|OncoImmunology|2014Cited by 17